Alogliptin administered to pregnant rabbits and rats during the period of organogenesis did not cause adverse developmental effects at doses of up to 200 mg kg and 500 mg kg, or 149 times and 180 times the 25 mg clinical dose, respectively, based on plasma drug exposure AUC cialis tadalafil free slots home 12345 slots free murka slots